Zyad T Saleh1, Ahmad T Alraoush, Ahmad A Aqel, Tagreed O Shawashi, Misook Chung, Terry A Lennie. 1. Zyad T. Saleh, PhD Associate Professor, School of Nursing, The University of Jordan, Amman, Jordan. Ahmad T. Alraoush Medical Student, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. Ahmad A. Aqel, PhD, RN Senior Lecturer, School of Nursing, The University of Jordan, Amman, Jordan. Tagreed O. Shawashi, MSN, RN Senior Lecturer, School of Nursing, The University of Jordan, Amman, Jordan. Misook Chung, PhD, RN Professor, College of Nursing, University of Kentucky, Lexington. Terry A. Lennie, PhD, FAAN Professor, College of Nursing, University of Kentucky, Lexington.
Abstract
BACKGROUND: Heart failure (HF) is associated with chronic inflammation, which is adversely associated with survival. Although sex-related differences in inflammation have been described in patients with HF, whether sex-related differences in inflammation are associated with event-free survival has not been examined. AIM: The aim of this study was to determine whether the association between inflammation as indicated by tumor necrosis factor-α and event-free survival differs between men and women with HF after controlling for demographic and clinical variables. METHOD: This was a secondary analysis of data from 301 male (age, 61.0 ± 11.4 years) and 137 female (age, 60.3 ± 12.1 years) patients with HF. Serum levels of soluble tumor necrosis factor receptor 1 were used to indicate inflammatory status. Patients were grouped according to median split of soluble tumor necrosis factor receptor 1 level and sex into male with low inflammation (≤1820 pg/mL) (n = 158) or high inflammation (>1820 pg/mL) (n = 143), and female with low inflammation (n = 63) or high inflammation (n = 74). Cox regression models were run separately for men and women to determine whether inflammation contributed to differences in event-free survival between sexes with HF. RESULTS: There were 84 male (27.9%) and 27 female (19.7%) patients who had an event. Event-free survival in women did not differ by the severity of inflammation in the Cox regression analysis. In contrast, men with high inflammation had 1.85 times higher risk for an event compared with men with low inflammation. CONCLUSION: These data provide evidence that inflammation contributed to differences in event-free survival in men but not women with HF. Clinicians should be aware that men who have higher inflammation may be at a greater risk of HF or cardiac-related events than others with HF.
BACKGROUND: Heart failure (HF) is associated with chronic inflammation, which is adversely associated with survival. Although sex-related differences in inflammation have been described in patients with HF, whether sex-related differences in inflammation are associated with event-free survival has not been examined. AIM: The aim of this study was to determine whether the association between inflammation as indicated by tumor necrosis factor-α and event-free survival differs between men and women with HF after controlling for demographic and clinical variables. METHOD: This was a secondary analysis of data from 301 male (age, 61.0 ± 11.4 years) and 137 female (age, 60.3 ± 12.1 years) patients with HF. Serum levels of soluble tumor necrosis factor receptor 1 were used to indicate inflammatory status. Patients were grouped according to median split of soluble tumor necrosis factor receptor 1 level and sex into male with low inflammation (≤1820 pg/mL) (n = 158) or high inflammation (>1820 pg/mL) (n = 143), and female with low inflammation (n = 63) or high inflammation (n = 74). Cox regression models were run separately for men and women to determine whether inflammation contributed to differences in event-free survival between sexes with HF. RESULTS: There were 84 male (27.9%) and 27 female (19.7%) patients who had an event. Event-free survival in women did not differ by the severity of inflammation in the Cox regression analysis. In contrast, men with high inflammation had 1.85 times higher risk for an event compared with men with low inflammation. CONCLUSION: These data provide evidence that inflammation contributed to differences in event-free survival in men but not women with HF. Clinicians should be aware that men who have higher inflammation may be at a greater risk of HF or cardiac-related events than others with HF.
Authors: Alexios S Antonopoulos; Marios Margaritis; Patricia Coutinho; Janet Digby; Rikhil Patel; Constantinos Psarros; Ntobeko Ntusi; Theodoros D Karamitsos; Regent Lee; Ravi De Silva; Mario Petrou; Rana Sayeed; Michael Demosthenous; Constantinos Bakogiannis; Paul B Wordsworth; Dimitris Tousoulis; Stefan Neubauer; Keith M Channon; Charalambos Antoniades Journal: Arterioscler Thromb Vasc Biol Date: 2014-07-24 Impact factor: 8.311
Authors: F D Richard Hobbs; Andrea K Roalfe; Russell C Davis; Michael K Davies; Rachel Hare Journal: Eur Heart J Date: 2007-04-25 Impact factor: 29.983
Authors: Terry A Lennie; Christina Andreae; Mary Kay Rayens; Eun Kyeung Song; Sandra B Dunbar; Susan J Pressler; Seongkum Heo; JinShil Kim; Debra K Moser Journal: J Am Heart Assoc Date: 2018-09-04 Impact factor: 5.501